TWD
VYGR icon

True Wealth Design’s Voyager Therapeutics VYGR Stock Holding History

True Wealth Design’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72K Buy
491
+83
+20% +$315 ﹤0.01% 1753
2026
Q1 		$1.57K Buy
408
+43
+12% +$169 ﹤0.01% 1635
2025
Q4 		$1.44K Buy
365
+1
+0.3% +$4 ﹤0.01% 1577
2025
Q3 		$1.7K Sell
364
-15
-4% -$54 ﹤0.01% 1529
2025
Q2 		$1.18K Sell
379
-5
-1% -$16 ﹤0.01% 1405
2025
Q1 		$1.3K Buy
+384
New +$1.79K ﹤0.01% 1171

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

True Wealth Design's VYGR Position: Q2 2026 in Review

True Wealth Design increased its Voyager Therapeutics (VYGR) stake by 20% in Q2 2026, buying an estimated $315 and bringing the position to 491 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

True Wealth Design first reported a position in VYGR in Q1 2025 and has held it in 6 quarters since. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • True Wealth Design held 491 shares of Voyager Therapeutics worth $1.72K as of Q2 2026.
  • True Wealth Design bought 83 Voyager Therapeutics shares in Q2 2026, an estimated $315.
  • Voyager Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1753 holding.
  • True Wealth Design first reported a position in Voyager Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.